Back
Corporate News
Of Rs 1.8 per share
Board of Lincoln Pharmaceuticals recommends final dividend
29-May-2026, 04:26
Lincoln Pharmaceuticals announced that the Board of Directors of the Company at its meeting held on 28 May 2026, inter alia, have recommended the final dividend of Rs 1.8 per equity Share (i.e. 18%) , subject to the approval of the shareholders.
Lincoln Pharmaceuticals announced that the Board of Directors of the Company at its meeting held on 28 May 2026, inter alia, have recommended the final dividend of Rs 1.8 per equity Share (i.e. 18%) , subject to the approval of the shareholders.